Granahan Investment Management’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-217,295
| Closed | -$1.35M | – | 198 |
|
|
2021
Q1 | $1.35M | Sell |
217,295
-177,515
| -45% | -$1.1M | 0.03% | 179 |
|
|
2020
Q4 | $2.94M | Sell |
394,810
-36,660
| -8% | -$273K | 0.07% | 156 |
|
|
2020
Q3 | $2.62M | Buy |
431,470
+186,093
| +76% | +$1.13M | 0.09% | 140 |
|
|
2020
Q2 | $2.05M | Sell |
245,377
-24,832
| -9% | -$207K | 0.07% | 154 |
|
|
2020
Q1 | $1.61M | Sell |
270,209
-115,671
| -30% | -$687K | 0.09% | 147 |
|
|
2019
Q4 | $2.5M | Sell |
385,880
-70,099
| -15% | -$455K | 0.12% | 129 |
|
|
2019
Q3 | $2.19M | Buy |
455,979
+16,896
| +4% | +$81.3K | 0.12% | 135 |
|
|
2019
Q2 | $1.76M | Buy |
439,083
+28,151
| +7% | +$113K | 0.09% | 150 |
|
|
2019
Q1 | $1.99M | Buy |
410,932
+45,999
| +13% | +$223K | 0.11% | 151 |
|
|
2018
Q4 | $2.33M | Buy |
364,933
+141,810
| +64% | +$905K | 0.16% | 123 |
|
|
2018
Q3 | $1.83M | Buy |
223,123
+166,121
| +291% | +$1.36M | 0.1% | 159 |
|
|
2018
Q2 | $595K | Buy |
57,002
+9,626
| +20% | +$100K | 0.04% | 190 |
|
|
2018
Q1 | $573K | Sell |
47,376
-11,668
| -20% | -$141K | 0.04% | 181 |
|
|
2017
Q4 | $592K | Buy |
59,044
+9,451
| +19% | +$94.8K | 0.05% | 184 |
|
|
2017
Q3 | $550K | Buy |
+49,593
| New | +$550K | 0.05% | 167 |
|